Approval · Notice of Compliance 13481 · 2012

TRELSTAR: Notice of Compliance 13481

Issued July 16, 2012

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 13481
Date: July 16, 2012
Company: Paladin Labs Inc
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Luteinizing Hormone-Releasing Hormone (LHRH) Analogue

Products in this notice

Brand	DIN	Status today
TRELSTAR	02240000	Marketed
TRELSTAR	02243856	Marketed

Medicinal ingredients

TRIPTORELIN PAMOATE 3.75 MG per VIAL
TRIPTORELIN PAMOATE 11.25 MG per VIAL